PetMed Express CEO Sandra Campos sells $200,090 in stock

Published 03/05/2025, 02:02
PetMed Express CEO Sandra Campos sells $200,090 in stock

Sandra Yvette Campos, CEO and President of PetMed Express Inc. (NASDAQ:PETS), recently sold shares of the company’s stock, according to an SEC filing. On April 30, Campos sold a total of 60,463 shares, generating proceeds of approximately $200,090. The shares were sold at prices ranging from $3.3087 to $3.3319 per share. The transaction comes as PETS shares have declined significantly over the past three months, with the stock currently trading at $3.62, giving the company a market capitalization of approximately $74 million.

The transactions were executed to cover tax withholding obligations related to the vesting of restricted stock units (RSUs). Following these sales, Campos holds 578,524 shares, which include 473,834 RSUs subject to vesting conditions. According to InvestingPro analysis, PetMed Express maintains strong financial health with more cash than debt on its balance sheet and liquid assets exceeding short-term obligations. Get access to 10+ additional exclusive ProTips and comprehensive analysis in the Pro Research Report.

In other recent news, PetMed Express reported third-quarter earnings that missed Wall Street expectations, with earnings per share at ($0.03), falling short of the anticipated ($0.01). Revenue also came in lower than expected at $53 million, compared to the forecasted $65 million. Despite the earnings miss, the company achieved a gross margin rate of 28.1%, an improvement from the previous year, and increased its adjusted EBITDA to $2 million. The company has been undergoing a transformation, adding Peter Batushansky to its Board of Directors and announcing the retirement of Dr. Gian Fulgoni. Morgan Stanley (NYSE:MS) adjusted its outlook on PetMed Express, reducing the price target from $3.50 to $3.20 while maintaining an Underweight rating. Analysts from Lake Street expressed caution about the company’s near-term prospects, reiterating a Hold rating due to ongoing competitive pressures. PetMed Express continues to focus on strategic initiatives to enhance customer experience and operational efficiency, with new management aiming to drive long-term shareholder value.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.